BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27183638)

  • 1. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
    Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
    J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
    Lamkin TJ; Chin V; Yen A
    Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R; Brown MH
    J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3.
    Hughan SC; Watson SP
    J Thromb Haemost; 2007 Feb; 5(2):387-94. PubMed ID: 17092301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dok1 and Dok2 proteins regulate natural killer cell development and function.
    Celis-Gutierrez J; Boyron M; Walzer T; Pandolfi PP; Jonjić S; Olive D; Dalod M; Vivier E; Nunès JA
    EMBO J; 2014 Sep; 33(17):1928-40. PubMed ID: 24963146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice.
    Ohsugi T
    J Vet Med Sci; 2017 May; 79(5):935-938. PubMed ID: 28302940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.
    Mihrshahi R; Barclay AN; Brown MH
    J Immunol; 2009 Oct; 183(8):4879-86. PubMed ID: 19786546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
    Ohsugi T; Wakamiya M; Morikawa S; Fujita M
    Acta Virol; 2016 Jun; 60(2):211-3. PubMed ID: 27265473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
    Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
    J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of DOK genes as lung tumor suppressors.
    Berger AH; Niki M; Morotti A; Taylor BS; Socci ND; Viale A; Brennan C; Szoke J; Motoi N; Rothman PB; Teruya-Feldstein J; Gerald WL; Ladanyi M; Pandolfi PP
    Nat Genet; 2010 Mar; 42(3):216-23. PubMed ID: 20139980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Dok-1 and Dok-2 in leukemia suppression.
    Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.
    Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS
    Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
    Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
    EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.
    Woodring PJ; Meisenhelder J; Johnson SA; Zhou GL; Field J; Shah K; Bladt F; Pawson T; Niki M; Pandolfi PP; Wang JY; Hunter T
    J Cell Biol; 2004 May; 165(4):493-503. PubMed ID: 15148308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.
    Lee S; Roy F; Galmarini CM; Accardi R; Michelon J; Viller A; Cros E; Dumontet C; Sylla BS
    Oncogene; 2004 Mar; 23(13):2287-97. PubMed ID: 14730347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
    J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.
    Hosooka T; Noguchi T; Kotani K; Nakamura T; Sakaue H; Inoue H; Ogawa W; Tobimatsu K; Takazawa K; Sakai M; Matsuki Y; Hiramatsu R; Yasuda T; Lazar MA; Yamanashi Y; Kasuga M
    Nat Med; 2008 Feb; 14(2):188-93. PubMed ID: 18204460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation.
    Nemeth MJ; Kirby MR; Bodine DM
    Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13783-8. PubMed ID: 16945912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.